DRUG PRICING & CHALLENGES TO HEPATITIS C TREATMENT ACCESS
- PMID: 30258323
- PMCID: PMC6152913
Item in Clipboard
DRUG PRICING & CHALLENGES TO HEPATITIS C TREATMENT ACCESS
J Health Biomed Law.
2018 Sep.
No abstract available
Similar articles
-
Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?Global Health. 2017 Sep 13;13(1):73. doi: 10.1186/s12992-017-0297-6. Global Health. 2017. PMID: 28903757 Free PMC article.
-
The Payer License Agreement, or "Netflix model," for hepatitis C virus therapies enables universal treatment access, lowers costs and incentivizes innovation and competition.Liver Int. 2022 Jul;42(7):1503-1516. doi: 10.1111/liv.15245. Epub 2022 Mar 26. Liver Int. 2022. PMID: 35289467 Free PMC article.
-
Strategies for Improving Hepatitis C Treatment Access in the United States: State Officials Address High Drug Prices, Stigma, and Building Treatment Capacity.J Public Health Manag Pract. 2019 May/Jun;25(3):245-252. doi: 10.1097/PHH.0000000000000829. J Public Health Manag Pract. 2019. PMID: 29927900 Free PMC article.
-
Pricing and Market Access Challenges in the Era of One-Time Administration Cell and Gene Therapies.Pharmaceut Med. 2022 Oct;36(5):265-274. doi: 10.1007/s40290-022-00443-x. Epub 2022 Aug 22. Pharmaceut Med. 2022. PMID: 35994198 Review.
-
How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.Appl Health Econ Health Policy. 2017 Jun;15(3):307-321. doi: 10.1007/s40258-016-0300-z. Appl Health Econ Health Policy. 2017. PMID: 28063134 Review.
Cited by
-
"Sell an Ox" - The Price of Cure for Hepatitis C in Two Countries.Int J Health Policy Manag. 2020 Jun 1;9(6):229-232. doi: 10.15171/ijhpm.2019.135. Int J Health Policy Manag. 2020. PMID: 32613790 Free PMC article.
-
Emerging trends in modeling human liver disease in vitro.APL Bioeng. 2019 Dec 24;3(4):040902. doi: 10.1063/1.5119090. eCollection 2019 Dec. APL Bioeng. 2019. PMID: 31893256 Free PMC article.
-
Contemporary Insights into Hepatitis C Virus: A Comprehensive Review.Microorganisms. 2024 May 21;12(6):1035. doi: 10.3390/microorganisms12061035. Microorganisms. 2024. PMID: 38930417 Free PMC article. Review.
-
The concept of justifiable healthcare and how big data can help us to achieve it.BMC Med Inform Decis Mak. 2021 Mar 6;21(1):87. doi: 10.1186/s12911-021-01444-7. BMC Med Inform Decis Mak. 2021. PMID: 33676513 Free PMC article. Review.
-
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya: A qualitative study.PLOS Glob Public Health. 2025 Jan 16;5(1):e0003284. doi: 10.1371/journal.pgph.0003284. eCollection 2025. PLOS Glob Public Health. 2025. PMID: 39821143 Free PMC article.
References
-
- Auerback David & Kellerman Arthur, A Decade Of Health Care Cost Growth Has Wiped Out Real Income Gains For An Average US Family, 30 Health Aff. 1630, 1634 (2011) (explaining the economic detriment of rising health care costs). - PubMed
-
- Henry J Kaiser Family Foundation, Health Care Costs: A Primer, Key Information on Health Care Costs and their Impact 7 (2007) (assessing the financial consequences of health care costs).
-
- Roehrig Charles & Rouseseau David, The Growth In Cost Per Case Explains Far More Of US Health Spending Increases Than Rising Disease Prevalence, 30 Health Aff. 1657, 1661 (2011) (evaluating the causes behind the increase in health care spending). - PubMed
-
- Kesselheim Aaron S. et al., The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform, 316 J. Am. Med. Assoc. 858, 858 (2016) (discussing causes of and prospective solutions for increased health care spending in the United States). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources